HeartSciences (HSCS) Receivables (2022 - 2025)
HeartSciences' (HSCS) quarterly Receivables came in at $4350.0 in Q4 2025, down 70.41% on a QoQ basis from $14700.0 in Q1 2024.
HeartSciences (HSCS) Receivables (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has 4 years of Receivables data on file, last reported at $4350.0 in Q4 2025.
- Quarterly Receivables changed N/A year-over-year to $4350.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4350.0 (changed N/A YoY) and the FY2025 annual result came in at $4350.0, changed N/A from the prior year.
- Receivables slipped to $4350.0 in Q4 2025, from $14700.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $14700.0 in Q1 2024 to a low of $2321.0 in Q2 2022.
- A 4-year average of $6317.8 and a median of $4125.0 in 2023 frame the typical range for Receivables.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.01 Bn |
| 10 | HeartSciences | 6.54 Mn | 4.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,350.00 |
| Jan 31, 2024 | 14,700.00 |
| Oct 31, 2023 | 3,900.00 |
| Apr 30, 2022 | 2,321.00 |